Sunvozertinib (DZD-9008) is a covalent/irreversible EGFR tyrosine kinase inhibitor with anticancer activity. Sunvozertinib is effective against EGFRexon20ins and other mutations.

纯度：≥98%

CAS：2370013-12-8